Us Bancorp \De\ Repare Therapeutics Inc. Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$8.63 - $12.53 $1,786 - $2,593	207 Added 63.5%	533 $5,000
Q1 2023 May 09, 2023	BUY	$9.32 - $15.06 $279 - $451	30 Added 10.14%	326 $3,000
Q4 2022 Feb 13, 2023	SELL	$12.5 - $18.13 $1,487 - $2,157	-119 Reduced 28.67%	296 $4,000
Q3 2022 Oct 27, 2022	SELL	$11.57 - $15.59 $4,373 - $5,893	-378 Reduced 47.67%	415 $5,000
Q2 2022 Aug 01, 2022	BUY	$8.45 - $14.84 $6,700 - $11,768	793 New	793 $11,000
Q3 2020 Nov 10, 2020	SELL	$21.55 - $33.92 $4,310 - $6,784	-200 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$30.8 - $32.99 $6,160 - $6,598	200 New	200 $6,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $57.9M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.